Innovent Biologics Inc (IVBIY)
19.48
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Innovent Biologics Total Assets (Quarterly): 2.910B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.910B |
| June 30, 2023 | 2.467B |
| June 30, 2023 | 2.467B |
| December 31, 2022 | 2.549B |
| June 30, 2022 | 2.411B |
| June 30, 2022 | 2.411B |
| December 31, 2021 | 2.548B |
| June 30, 2021 | 2.545B |
| June 30, 2021 | 2.545B |
| December 31, 2020 | 1.811B |
| Date | Value |
|---|---|
| June 30, 2020 | 1.263B |
| June 30, 2020 | 1.263B |
| December 31, 2019 | 1.033B |
| June 30, 2019 | 813.86M |
| June 30, 2019 | 813.86M |
| December 31, 2018 | 888.59M |
| June 30, 2018 | 738.32M |
| June 30, 2018 | 738.32M |
| December 31, 2017 | 376.37M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
813.86M
Minimum
Jun 2019
2.910B
Maximum
Dec 2023
1.990B
Average
2.411B
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 13.66B |
| CASI Pharmaceuticals Inc | 75.27M |
| Zai Lab Ltd | 988.44M |
| Gracell Biotechnologies Inc (DELISTED) | 259.03M |
| Adagene Inc | 115.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.143B |
| Shareholders Equity (Quarterly) | 1.767B |
| Debt to Equity Ratio | 0.2811 |
| Current Ratio | 3.000 |
| Net Debt Paydown Yield | -0.39% |